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Nutritional studies on humans and animals havelong back established the role of vitamins andmineral elements in health1. For many phylogenic
groups these are essential i.e. they have to be supplied in
the diet as, such organisms like humans have lost the
ability to biosynthesize these dietary components. While
a lot of biochemical work has been done on the dietary
carbohydrate, protein and lipid metabolism in generating,
storing and utilizing energy for living processes2, the
metabolic link between the biochemical reaction in which
the vitamin takes part and the disease precipitated in their
absence is not clearly understood. This is true for many
genetic disorders also where establishing cause and effect
metabolic link between gene defect and a phenotype like
mental disorder is proving to be difficult. Reproduction in
higher animals is a complex physiological process resulting
in progeny generation3. Vitamins like vitamin E (alpha
tocopherol) are essential for successful reproduction in
many higher animals4. Other vitamins like ascorbic acid,
riboflavin, niacin and thiamine directly or indirectly are
required for reproductive success. In oviparous animals,
these vitamins are supplied by the female adult through
the egg yolk to the new generation during development5.
But during the adult stage, they have to be obtained
through diet. Reproductive hormones of pituitary and
gonadal origin regulate many reproductive physiological
processes6,7. One of the known actions of the pituitary
luteinizing hormone (LH) is to cause depletion of the
ovarian ascorbic acid content and this in effect forms the
basis of a reliable bioassay for this hormone7. What is
not known clearly is the mechanism by which this depletion
is brought about. In animals like rats and mice, it could be
envisaged that LH must be affecting, either the
biosynthesis or catabolism or both, of ascorbic acid in the
ovary. The famous 'Parlow rat' is the experimental model
to demonstrate this bioassay. Briefly 25-26 day old
immature rats of Holtzman or any other strain are
administered Pregnant Mare Serum Gonadotrophin (PMSG)
and human Chorionic Gonadotrophin (hCG) in sequence
to accelerate ovarian follicular growth (hyperplasia and
hypertrophy) and induce super ovulation (Fig 1).
Fig. 1. Ovarian ascorbic acid depletion assay as proposed by A.F.
Parlow (1961).
Five to seven days after the administration of hCG,
the animals receive the standard doses of LH or unknown
substance suspected of possessing LH like activity. Four
hours later the animals are sacrificed and the ovarian
ascorbic content is estimated (Fig 2).
234 SCIENCE AND CULTURE, JULY-AUGUST, 2010
Fig. 2. Dose response to hCG in OAAD assay.
As said earlier the signalling pathway for this effect
of LH is not understood. Our preliminary experimental
results indicated that cAMP (Adenosine-3', 5' cyclic
monophosphate), the famous second messenger could
mediate this action of LH8 (Table 1). It was also shown to
be cycloheximide insensitive (Table 2).
TABLE 1. Effect of cyclic nucleotides on ovarian ascorbic
acid content.
Group No. Treatment* Dose Ascorbic acid Change in
(μg/rat)* Mg (%) Ascorbic
(Mean ± S.D.) acid (%)
I Saline – 77.11 ± 9.5 0.00
II 5'-AMP 20 79.69 ± 5.1 +3.35a
III dbcAMP 5 71.87 ± 2.6 -6.79b
IV dbcAMP 20 73.40 ± 5.1 -4.81c
V eGMP 20 61.65 ± 5.1 -20.04d
VI saline – 89.84 ± 11.3 0.00
VII dbcAMP 50 77.84 ± 8.5 -13.36e
* Wistar strain rats were used.
a p > 0.1; d.f. = 10 (I:II)
b p > 0.1; d.f. = 8 (I:III)
c p > 0.1; d.f. = 9 (I.IV)
d p < 0.025; d.f. = 9 (I:V)
e p = 0.05; d.f. = 10 (VI:VII)
Ascorbic acid prevents apoptosis in mice follicles
exposed to folicle stimulating hormone (FSH) in serum-
free media. It is reported to promote follicular integrity. It
does not affect estrogen production or follicular growth.
It may have a role in remodelling of follicular cells.
Metalloproteinase 1 inhibitor and metalloproteinase 2 tend
to increase in ovarian follicles by the addition of ascorbic
acid. Ascorbic acid does not appear to have progesterone
like function. It is known to prevent apoptosis in ovary.
LH induced luteolysis results in increase in lipid
peroxidation, decrease in ascorbic acid and decrease in
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Figure 3. Different biosynthetic pathways of L-ascorbic acid in
animals (reactions 1–8) and plants (reactions 9-24). Adapted from,
V. Valpuesta and M.A. Botella, Trends Plants Sci., 9,573 (2004).
TABLE 2. Inability of cycloheximide to block LH action
on ovarian ascorbic acid.
Group No. Treatment* Dose Ascorbic acid Depletion
(μg/rat)* Mg (%) (%)
(Mean ± S.D.)
I Saline – 89.84 ± 11.20 0.00
II LH 3.2 50.59 ± 5.02
43.68a
III LH+Cyclo- 3.2 + 250 53.36 ± 11.83
40.67b heximide
* Wistar strain rats were used.
a. p < 0.005; d.f. = 9 (I:II)
b. 0.25 > p> 0.1; d.f. = 9 (II:III)
VOL. 76, NOS. 7–8 235
progesterone. LH increases estrogen but decreases
ascorbic acid content in ovaries8. Ascorbic acid augments
ovulation induction by clomiphene.
A perusal of ascorbic acid metabolism in animals10,
plants11 and microbes indicate that more than one metabolic
pathway exists for the biosynthesis of ascorbic acid in
different phylogenic groups (Fig 3).
A common feature is that the immediate precursor
metabolite in the biosynthetic pathway is L-gulonolactone
which gets converted to L-ascorbic acid via 2-keto
L-gulonolactone and this reaction is catalysed by
L-gulonolactone oxidase (LGO)12. This enzyme is
apparently absent in humans, other primates, guineapigs
and fist12. It is also known that ascorbic acid undergoes
an interesting catabolic transformation to oxalate and
L-Threose via dehydroascorbate and diketoascorbate13.
The enzymatic details are not clear. Ascorbic acid oxidase,
however, inactivates ascorbate by oxidising it to
dehydroascorbate. While outside the living tissue,
ascorbate easily gets oxidised by air, there are reports that
inside tissues, the equilibrium lies towards ascorbate11.
However this is not substantiated well. L-gulonolactone is
derived from L-gulonic acid or D-glucuronolactone or even
D-galacturono lactone12. In the case of conversion of
D-glucuronic acid to L-gulonic acid there is inversion as
these are not mirror images. But in the case of conversion
of D-galacturonic acid to L-galactonic acid, there is no
inversion13. It is evident that other important enzymes in
TABLE 3. Hydroxyapatite column enables purification of L-Gulonate Dehydrogenase
from Kidney.
S.No. Sample Volume Protein Activity Specific Yield* Purification
(mL) (mg) (μmol/min) Activity (%) Fold
(U/mg)
1. Cytosol 580 6845 11.88 0.0017 100 1.00
2. (NH4)2SO4 138 3844 150.22 0.0391 1264 22.51
ppt (60% S)
3. HA unbound 200 1294 211.45 0.1635 1779 94.18
*Yield increase upon salt fractionation indicates possible presence of inhibitor in the cytosol.
The nature of the inhibitor is yet to be investigated
TABLE 4. Comparison of tissue and recombinant enzyme.
Initial activity* Yield (%) Specific activity of the final preparation
(U/mg protein)
t-enzyme * 1 Unit/gram tissue/34 mg protein
r-enzyme 48 55 Units/Litre/78 mg protein
*Every of t-enzyme strangely goes more than 100% due to increase after a certain fractionation.
this pathway from D-glucuronic acid are D-glucuronate
reductase, L-gulonate dehydrogenase and the lactonase.
These facts raise many questions about the possible effects
of LH on the enzymes of ascorbic acid biosynthesis and
degradation in the rat ovary. One notices also that the
uronate pathway of glucose degradation via myo inositol,
D-glucuronic acid and L-gulonate normally leads to the
formation of L-xylulose and then to xylitol (Fig 4).
This places L-gulonic acid at a crucial metabolic traffic
junction where it can get metabolised to either xylitol or
ascorbic acid.
The question that arises is what external factors
control this channelling of L-gulonate into either of the
two possible pathways ? Alternately, one can envisage a
situation where L-gulonate is not transformed to ascorbate
under normal conditions. Under special conditions, it is
possible that L-GuDH is blocked, thus formation of xylitol
is blocked and hence ascorbate content is increased. Does
such a situation in reverse occur in the ovary ? LH causes
depletion of ascorbic acid in the ovary. Hence either the
biosynthesis is blocked or the degradation is accelerated
by the putative external factor. What is the effect of LH
on rat ovarian ascorbic acid
oxidase, L-gulonolactone
oxidase, L-GuDH, and
D-glucuronate reductase etc. ?
The more interesting fact is that
excessive formation of xylitol
and excretion through kidney is
one of the factors leading to
precipitation of diabetic
nephropathy in chronic
diabetes14. In order to
understand this problem, hog
kidney L-GuDH was purified to
homogeneity. Data related to
part of the purification process
is given in Table 3.
Our experience showed
that approximately one unit of
this enzyme activity was present
in one gram of the tissue
(Table 4).
D-Xylulose L-gulonic acid L-ascorbic acid
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TABLE 5. Purification of Recombinant L-GuDH with His-tag.
S.No. Sample Volume Protein Activity Specific Yield* Purification
(mL) (mg) (μmol/min) Activity (%) Fold
(U/mg)
1. Bacterial 40 156 0.111 0.7 100 1.00
Extract
2. (NH4)2SO4 16 75 0.057 0.8 51 1.07
ppt (60% S)
3. Blue-agarose 32 59 0.062 1.0 56 1.18
Unbound
4. HA unbound 125 19 0.06 3.2 54 4.46
5. HA unbound 1.1 16 0.055 3.4 49 4.89
concentrate
6. S-200 pool I 3.5 6.5 0.06 9.44 48 13.4
*Later it was found that in the case of the r-enzyme without His-tag, one can skip the HA
step and go directly to DE-52 and S-200 to get the pure enzyme.
We could get more than 245
fold purification by including
additional steps like DE-52 and S-
300 chromatographies. The final
preparation had a specific activity
of 7 units per mg protein. The
cDNA for L-GuDH was also made
and cloned without and with HIS-
tag in pET 17b and pET 28a
vectors (data not shown). The
recombinant enzyme, purified
13.4-fold from crude bacterial
extract (Table 5).
It had a specific activity of
9 units per mg protein. An
interesting property of the hog
kidney L-GUDH must be noted.
Although reports exist in
literature that rabbit eye L-GUDH
can be purified on Blue-
sepharose, it was observed that
the hog kidney enzyme, both
native and the recombinant types,
did not bind to Blue-4 or Blue-2
sepharose. This is puzzling as the
enzyme is a pyridine-linked
dehydrogenase (Table 6).
The native and the
recombinant enzymes were
characterised with regard to
physico-chemical and
immunological properties (data not
shown). The enzyme could
oxidise, in additon to L-gulonate
(The KM Value was between 2.10
mM to 2.75 mM), D-gluconic acid,
L-malic acid and beta hydroxyl
butyric acid  (Table 7).
The reported activity of this
native enzyme on L-arabonic acid
is not easily explainable14. There
were other interesting aspects of
its substrate specificity. For
example the recombinant L-GUDH
had significant activity on L-malic
acid and L-threonone but the
native enzyme did not act on
these substrates (Table 7).
It was also observed that
four naturally occurring
Figure 4. Vitamin C biosynthesis pathway and pentose pathway in animals. Adapted from
C.L. Linster and E.V. Schaftingen, FEBS J., 274, 1 (2007).
Vitamin C symthesis pathway
Pentose pathway
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metabolites inhibited the enzyme to varying extent i.e. 55%
to 100% (data not shown). However, in one case, i.e. D-
Glucoronic Acid (Fig. 5), the Ki was 12.9 mM and the
inhibition was of a mixed type.
Fig 5. D-Glucoronic Acid, a powerful inhibitor of L-GuDH.
Metabolism of phosphorylated sugars has drawn more
attention from scientists that of non-phosphorylated
sugars. Many eye lens crystallins have been shown to
possess gulonate dehydrogenase activity15. When the
crystallin gene from rabbit eye lens was cloned and the
cDNA sequenced, it matched with that of kidney gulonate
dehydrogenase15.
Xylose feeding to adult rats has been shown to result
in cataract16. But aldose reductase activity in the adult rat
eye lens is not significant to account for xylitol formation
which is necessary for the manifestation of cataract
condition. In young rats the same xylose feeding does
not precipitate any cataract formation. It was suggested,
using 14C-labelled sugars, that the myo inositol metabolism
to xylulose, the equilibrium and conversion of fed xylose
to xylulose and the action of L-iditol-NAD+ oxidoreductase
causes the formation of xylitol and thus cataract16.
In conclusion, studies from many laboratories
including ours have shown that L-gulonate dehydrogenase
is an important enzyme which can control the metabolite
flux towards either of the metabolic pathways (formation
of ascorbic acid or xylitol) at a crucial metabolic traffic
junction. ?
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TABLE 6. Recombinant L-GuDH does not bind
Cibacron Blue
Sample Affinity Column Unbound/Bound
Activity (%)
ALR-1 Blue-4-agarose 70/33
r-L-GuDH Blue-4-agarose >95/0.0
r-L-GuDH Blue-4-agarose >95/0.0
(5mM pH 8.0)
r-L-GuDH Blue-2-agarose >95/0.0
BSA Blue-2-agarose 0.0/100
Table 7. Activity against different substrates
Activity (%)
Substarte (t-enzyme) (r-enzyme)
L-Gulonic acid 100 100
L-Malic acid 0 27
D-Gluconic acid 36 N.D.
L-Thereonine 0 10-15
R(-) 3-OH butyric acid 6 N.D.
HO
HO
O
D-glucuronic acid
OH
HOO OH
